Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enbrel in pediatric plaque psoriasis
NCT00078819Phase 3Completed
- Sponsor
- Amgen
- Start
- Sep 2004
- Primary completion
- Feb 2006
- Modality
- Fc-Fusion Proteins
01
Overview
Phase 3, randomised, double-blind trial in plaque psoriasis comparing Placebo Arm with Etanercept Arm (2 arms). Primary endpoint: Psoriasis Area and Severity Index 75% Improvement at 12 weeks. Started Sep 2004; status: completed.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00078819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00078819.